Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evolent Health, Inc (EVH : NYSE)
 
 • Company Description   
Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia.

Number of Employees: 4,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.02 Daily Weekly Monthly
20 Day Moving Average: 3,173,776 shares
Shares Outstanding: 111.60 (millions)
Market Capitalization: $448.64 (millions)
Beta: 0.28
52 Week High: $12.98
52 Week Low: $3.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.85% -8.23%
12 Week -54.16% -55.61%
Year To Date -64.27% -69.44%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1812 NORTH MOORE ST SUITE 1705
-
ARLINGTON,VA 22209
USA		 ph: 571-389-6000
fax: 571-389-6001		 investorrelations@evolent.com http://www.evolent.com
 
 • General Corporate Information   
Officers
Seth Blackley - Chief Executive Officer and Director
John Johnson - Chief Financial Officer
Aammaad Shams - Chief Accounting Officer
Toyin Ajayi - Director
Craig Barbarosh - Director

Peer Information
Evolent Health, Inc (HLIS)
Evolent Health, Inc (AZTA)
Evolent Health, Inc (APYI)
Evolent Health, Inc (RNVA)
Evolent Health, Inc (HMSY)
Evolent Health, Inc (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 30050B101
SIC: 8741
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/19/26
Share - Related Items
Shares Outstanding: 111.60
Most Recent Split Date: (:1)
Beta: 0.28
Market Capitalization: $448.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.34 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/19/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.53
Price/Cash Flow: 2.65
Price / Sales: 0.22
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: 52.94%
Sales Growth
vs. Year Ago Period: -22.83%
vs. Previous Quarter: 7.92%
ROE
09/30/25 - 1.79
06/30/25 - 1.83
03/31/25 - 3.64
ROA
09/30/25 - 0.65
06/30/25 - 0.70
03/31/25 - 1.44
Current Ratio
09/30/25 - 1.33
06/30/25 - 1.01
03/31/25 - 0.98
Quick Ratio
09/30/25 - 1.33
06/30/25 - 1.01
03/31/25 - 0.98
Operating Margin
09/30/25 - 0.80
06/30/25 - 0.81
03/31/25 - 1.53
Net Margin
09/30/25 - -6.24
06/30/25 - -5.94
03/31/25 - -4.54
Pre-Tax Margin
09/30/25 - -6.22
06/30/25 - -5.99
03/31/25 - -4.56
Book Value
09/30/25 - 7.55
06/30/25 - 7.63
03/31/25 - 7.97
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - 1.25
06/30/25 - 0.72
03/31/25 - 0.69
Debt-to-Capital
09/30/25 - 55.60
06/30/25 - 36.57
03/31/25 - 36.45
 

Powered by Zacks Investment Research ©